Penumbra, Inc. (PEN)
NYSE: PEN · Real-Time Price · USD
243.01
-9.26 (-3.67%)
Aug 1, 2025, 4:00 PM - Market closed
Chimerix Market Cap
Penumbra has a market cap or net worth of $9.41 billion as of August 1, 2025. Its market cap has increased by 23.39% in one year.
Market Cap
9.41B
Enterprise Value
9.21B
1-Year Change
23.39%
Ranking
Category
Stock Price
$243.01
Market Cap Chart
Since September 18, 2015, Penumbra's market cap has increased from $1.23B to $9.41B, an increase of 663.68%. That is a compound annual growth rate of 22.86%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 31, 2025 | 9.84B | 7.94% |
| Dec 31, 2024 | 9.11B | -6.12% |
| Dec 29, 2023 | 9.71B | 14.91% |
| Dec 30, 2022 | 8.45B | -21.29% |
| Dec 31, 2021 | 10.73B | 68.92% |
| Dec 31, 2020 | 6.35B | 10.79% |
| Dec 31, 2019 | 5.74B | 36.03% |
| Dec 31, 2018 | 4.22B | 32.02% |
| Dec 29, 2017 | 3.19B | 58.19% |
| Dec 30, 2016 | 2.02B | 25.52% |
| Dec 31, 2015 | 1.61B | 30.52% |
| Sep 18, 2015 | 1.23B | - |
View and export this data all the way back to 2015. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 683.89B |
| Johnson & Johnson | 400.96B |
| AbbVie | 345.21B |
| AstraZeneca | 236.88B |
| UnitedHealth Group | 230.14B |
| Novartis AG | 227.02B |
| Abbott Laboratories | 223.36B |
| Novo Nordisk | 221.96B |